Improving Canine Lymphoma Treatment Outcomes by Individualizing Drug Selection using Machine-Learning-Based Predictive Models

April 20, 2024

Presentation Detail

Speakers:
- Sungwon Lim, PhD, CEO & Co-Founder of ImpriMed, Inc.
- Joseph Impellizeri DVM, DACVIM (Oncology), MRCVS of Veterinary Oncology Services

Date: April 20, 2024
Venue: Cornell University College of Veterinary Medicine

Description: The presentation will provide functional perspectives on integrating AI and veterinary oncology by examining ImpriMed’s pioneering approach to personalized drug response predictions. ImpriMed’s clinical results, based on thousands of real-world canine lymphoma and leukemia patients, boast three-fold longer survival times and four-fold longer remission in relapsed B-cell canine lymphoma and high-grade T-cell canine lymphoma, improving the efficacy and speed of patient treatment.

Presentations

Boosting the power of AI-based treatment outcome predictions for canine lymphoma by combining tumor and germline genetic biomarkers and live-cell analytics

Veterinary Cancer Society Annual Conference 2024

Novel Genetic Biomarkers of Chemotherapeutic Response in Canine Lymphoma and Improved Predictive Power With Integration of Machine Learning

Veterinary Cancer Society Annual Conference 2024

Decoding Feline Lymphoma: From Diagnosis to Prognosis

Veterinary Cancer Society Annual Conference 2024

Dramatically increased clinical remission rates and survival times in dogs with high-grade T-cell lymphoma and relapsed B-cell lymphoma in clinical study of AI decision support

World Veterinary Cancer Congress 2024

Treatment-specific risk stratification of feline lymphoma based on unsupervised clustering of flow cytometry results

World Veterinary Cancer Congress 2024

AI-driven Personalized Medicine for Cancer Care

Precision Medicine World Conference 2024

Increased survival and remission rates in prospective study of relapsed B-cell lymphoma patients treated by oncologists using ImpriMed's AI predictions

Veterinary Cancer Society Annual Conference 2023

Canine Lymphoma Diagnostics Past, Present and Future: How AI technology and genetics are pushing the boundaries in veterinary medicine

Veterinary Cancer Society Annual Conference 2023

Impact of AI on clinical practice and outcome

Veterinary Cancer Society Annual Conference 2023

Identification of drug response biomarkers for canine lymphoma in large-scale NGS screen

Veterinary Cancer Society Annual Conference 2023

ImpriMed: AI-driven Personalized Medicine for Pet Cancer Care

Veterinary Cancer Society-Veterinary Society of Surgical Oncology Collaborative Conference 2023

Reinventing precision medicine: from dogs to humans

Precision Medicine World Conference 2023

Identification of Novel Predictive Biomarkers of Anticancer Drug Responses in Canine B-Cell Lymphoma Using Targeted NGS

Veterinary Cancer Society Annual Conference 2022

ImpriMed Research Update

Veterinary Cancer Society Annual Conference 2022

Drugs predicted to be effective using artificial intelligence (AI) double the clinical response rate in canines with relapsed B-cell lymphoma

Veterinary Cancer Society Mid-Year Conference 2022

ImpriMed Research Update

Veterinary Cancer Society Mid-Year Conference 2022

Precision medicine for pet cancer care

Animal Health, Nutrition and Technology Innovation Europe 2022

Predicting dynamic clinical outcomes of (L-)CHOP chemotherapy for canine lymphoma patients using an artificial intelligence model

Veterinary Cancer Society Annual Conference 2021

ImpriMed: Experiences from the eyes of an oncologist in clinical practice

Veterinary Cancer Society Annual Conference 2021

Predicting likelihood of in vivo chemotherapy response in canine lymphoma using ex vivo drug sensitivity and immunophenotyping data in a machine learning model

Veterinary Cancer Society Annual Conference 2020

ImpriMed: A data-driven, personalized chemotherapy drug testing service for canine blood cancer patients

Veterinary Cancer Society Annual Conference 2021

Individualizing chemotherapy for canine lymphoma based on ex vivo drug sensitivity test

World Veterinary Cancer Congress 2020

From dog to human: precision medicine for comparative oncology

Precision Medicine World Conference 2020

NYC Oncology Conference 2019

ImpriMed: precision medicine for pet cancer care

NYC Oncology Conference 2019

Individualizing chemotherapy for canine lymphoma based on ex vivo drug sensitivity test

Veterinary Cancer Society Annual Conference 2019